STAAR Surgical Company (STAA) revenue and earnings history
STAAR Surgical Company reported revenue of $239M for fiscal 2025 (year ended Jan 2, 2026), −23.7% on the year before, and net income of −$80.4M.
Over 16 years, from fiscal 2009 to fiscal 2025, revenue grew at a compound rate of +10.1% a year.
Revenue and net income, 17 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Jan 2, 2026 | $239M−23.7% | −$91.7M | −$80.4M | −$34.2M | $5.82M | −$40M | $30.6M | $6.46M | — | $153M | — | 10-K |
| 2024ended Dec 27, 2024 |
The latest quarter, insider trades and fund moves: STAAR Surgical Company (STAA) on OQRO.
Common questions
What was STAAR Surgical Company's revenue in fiscal 2025?
$239M for the year ended Jan 2, 2026, as reported in its 10-K filed Mar 3, 2026. That is −23.7% on fiscal 2024 ($314M).
How fast has STAAR Surgical Company's revenue grown?
From $51.1M in fiscal 2009 to $239M in fiscal 2025: a compound annual growth rate of +10.1% over 16 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure STAAR Surgical Company tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
